Mobius syndrome is a rare congenital disorder with the preliminary diagnostic criteria of congenital facial and abducent nerve palsy. Involvement of other cranial nerves, too, is common. Prevalence rate of this syndrome is approximately 1 in 100,000 neonates. It is of unknown etiology with sporadic occurrence. However, data regarding the occurrence rate in India is limited. Features such as orofacial malformations, limb defects, and musculoskeletal, behavioral, and cognitive abnormalities might be associated. A thorough evaluation to identify the condition and establishing an adequate treatment plan is of utmost important in this condition. We are reporting clinical and radiographic features of Mobius syndrome in two cases along with unusual findings of limb and neck deformity.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390129 | PMC |
http://dx.doi.org/10.15171/joddd.2017.012 | DOI Listing |
Pediatr Int
September 2024
Department of Pediatrics, Faculty of Medicine, Kagawa University, Kitagun, Kagawa, Japan.
J Plast Reconstr Aesthet Surg
November 2024
Division of Plastic Surgery, Indiana University School of Medicine, USA. Electronic address:
Acta Psychol (Amst)
September 2024
Ludwigsburg University of Education, Germany.
Genes (Basel)
July 2024
Medical Genetics, Department of Health Sciences, Università degli Studi di Milano, 20142 Milan, Italy.
Moebius syndrome (MBS) is a rare congenital disorder characterized by non-progressive facial palsy and ocular abduction paralysis. Most cases are sporadic, but also rare familial cases with autosomal dominant transmission and incomplete penetrance/variable expressivity have been described. The genetic etiology of MBS is still unclear: de novo pathogenic variants in and are reported in only a minority of cases, suggesting the involvement of additional causative genes.
View Article and Find Full Text PDFArch Gynecol Obstet
September 2024
Obstetrics and Gynecology Hospital, Fudan University, Shanghai, 200011, People's Republic of China.
Purpose: This meta-analysis aimed to comprehensively assess the teratogenic risk to offspring associated with continuing pregnancy after administering mifepristone and/or misoprostol during gestation.
Methods: We conducted a systematic search of multiple databases, including PubMed, Web of Science, Embase, Cochrane, CNKI, and CBM, from their inception to February 2024, with no language restrictions. We included cohort and case-control studies that analyzed the teratogenic effects of mifepristone and/or misoprostol on fetuses and newborns.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!